Under hypoxic conditions, the transcription levels of 5-LOX and ALOX5AP in ovarian cancer cell lines also increase, significantly correlating with poor overall survival, progression-free survival, lymphatic infiltration after initial treatment, rapid relapse, and other adverse clinical pathological features. Here, ALOX5 is linked to ovarian carcinoma.